Multifocal brain damage induced by phencyclidine is augmented by pilocarpine

Brain Research

Volumn 752, Issue 1-2, 1997, Pages 1-14

  Corso, T D ^a   Tenkova, T I ^a   Sesma, M A ^a   Der, T C ^a   Wozniak, D F ^a   Farber, N B ^a   Olney, J W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

de Olmos silver staining; haemotoxylin and eosin; heat shock protein immunocytochemistry; neurodegeneration; neurotoxicity; NMDA antagonists; phencyclidine; retrosplenial granular cortex

Indexed keywords

HEAT SHOCK PROTEIN; PHENCYCLIDINE; PILOCARPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; HISTOLOGY; IMMUNOCYTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BRAIN; BRAIN DAMAGE, CHRONIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FEMALE; NERVE DEGENERATION; PHENCYCLIDINE; PILOCARPINE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0343307121     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01347-9     Document Type: Article

References (30)

1. Allen, H.L. and Iversen, L.L., Phencyclidine, dizocilpine, and cerebrocortical neurons, Science, 247 (1990) 221.
2. Corso, T.D., Der, T.C., Tenkova, T.I., Labruyere, J., Wozniak, D.F. and Olney, J.W., Disseminated neuronal necrosis induced by phencyclidine (PCP) in rat brain: Effect of co-treatment with pilocarpine, Soc. Neurosci. Abstr., 21 (1995) 351.
3. de Olmos, J., Ebbesson, S. and Heimer, L., Silver methods for the impregnantion of degenerating axoplasm. In L. Heimer and N. Robards (Eds.), Neuroanatomical Tract-tracing Methods, Plenum, New York, 1981, pp. 117-168.
4. Domino, E.F. and Luby, E.D., Abnormal mental states induced by phencyclidine as a model of schizophrenia. In E.F. Domino (Ed.), PCP (Phencyclidine): Historical and Current Perspectives, NPP Books, Ann Arbor, 1981, pp. 401-418.
5. Ellison, G., Competitive and non-competitive NMDA antagonists induce similar limbic degeneration, NeuroReport, 5 (1994) 2688-2692.
6. Ellison, G. and Switzer, R.C., Dissimilar patterns of degeneration in brain following four different addictive stimulants, NeuroReport, 5 (1993) 17-20.
7. Farber, N.B., Foster, J., Duhan, N.L. and Olney, J.W., Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity, Schizophrenia Res., 21 (1996) 33-37.
8. Farber, N.B. and Olney, J.W., α2 adrenergic agonists prevent MK-801 neurotoxicity, Neuropsychopharmacology, 12 (1995) 347-349.
9. Farber, N.B., Price, M.T., Labruyere, J., Nemnich, J., St Peter, H., Wozniak, D.F. and Olney, J.W., Antipsychotic drugs block phencyclidine receptor-mediated neurotoxicity, Biol. Psychiatry, 34 (1993) 119-121.
10. Farber, N.B., Wozniak, D.F., Price, M.T., Labruyere, J., Huss, J., St. Peter, H. and Olney, J.W., Age specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia? Biol. Psychiatry, 38 (1995) 788-796.
11. Fix, A.S., Horn, J.W., Wightman, K.A., Johnson, C.A., Long, G.G., Storts, R.W., Farber, N., Wozniak, D.F. and Olney, J.W., Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK( + )801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex, Exp. Neurol., 123 (1993) 204-215.
12. Fix, A.S., Wozniak, D.F., Truex, L.L., McEwen, M., Miller, J.P. and Olney, J.W., Quantitative analysis of factors influencing neuronal necrosis induced by MK-801 in the rat posterior cingulate/retrosplenial cortex, Brain Res., 696 (1995) 194-204.
13. Grotta, J., Clark, W., Coull, B., Pettigrew, L.C., Mackay, B., Goldstein, L.B., Murphy, D. and LaRue, L., Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial, Stroke, 26 (1995) 602-605.
14. Hargreaves, R.J., Rigby, M., Smith, D., Hill, R.G. and Iversen, L.L., Competitive as well as uncompetitive N-methyl-D-aspartate receptor antagonists affect cortical neuronal morphology and cerebral glucose metabolism, Neurochem. Res., 18 (1993) 1263-1269.
15. Herrling, P., D-CPPene (SDZ EAA 494), a competitive NMDA antagonist. Results from animal models and first results in humans, Neuropsychopharmacology, 10 (3S/Part 1) (1994) 591S.
16. Horvath, Z. and Buzsaki, G., MK-801-induced neuronal damage in normal rats, Soc. Neurosci. Abstr., 19 (1993) 354.
17. Javitt, D.C. and Zukin, S.R., Recent advances in the phencyclidine model of schizophrenia, Am. J. Psychiatry, 148 (1991) 1301-1308.
18. Kristensen, J.D., Svensson, B. and Gordh, T., Jr., The NMDA receptor-antagonist CPP abolishes neurogenic 'wind-ssup pain' after intrathecal administration in humans. Pain, 51 (1992) 249-253.
19. Krystal, J.H., Karper, L.P., Seibyl, J.P., Freeman, G.K., Delaney, R., Bremner, J.D., Heninger, G.R., Bowers, M.B., Jr. and Charney, D.S., Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses, Arch. Gen. Psychiatry, 51 (1994) 199-214.
20. Lodge, D. and Anis, N.A., Effects of phencyclidine on excitatory amino acid activation of spinal interneurones in the cat, Eur. J. Pharmacol., 77 (1982) 203-204.
21. Lodge, D., Aram, J.A., Church, J., Davies, S.N., Martin, D., O'Shaughnessey, C.T. and Zeman, S., Excitatory amino acids and phencyclidine-like drugs. In T.P. Hicks, D. Lodge and H. McLennan (Eds.), Excitatory Amino Acid Transmission, Alan R. Liss Inc., New York, 1987, pp. 83-90.
22. Nakki, R., Koistinaho, J., Sharp, F.R. and Sagar, S.M., Cerebellar toxicity of phencyclidine, J. Neurosci., 15 (1995) 2097-2108.
23. Olney, J.W., Labruyere, J. and Price, M.T., Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs, Science, 244 (1989) 1360-1362.
24. Olney, J.W., Labruyere, J., Wang, G., Wozniak, D.F., Price, M.T. and Sesma, M.A., NMDA antagonist neurotoxicity: mechanism and prevention, Science, 254 (1991) 1515-1518.
25. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1986.
26. Price, M.T., Farber, N.B., Labruyere, J., Foster, J. and Olney, J.W., Tracing the circuitry that mediates NMDA antagonist neurotoxicity, Soc. Neurosci. Abstr., 20 (1994) 1532.
27. Reich, D.L. and Silvay, G., Ketamine: an update on the first twenty-five years of clinical experience. Can. J. Anaesthesiol., 36 (1989) 186-197.
28. Sharp, F.R., Butman, M., Koistinaho, J., Aardalen, K., Nakki, R., Massa, S., Swanson, R.A. and Sagar, S.M., Phencyclidine induction of the hsp70 stress gene in injured pyramidal neurons is mediated via multiple receptors and voltage gated calcium channels, Neuroscience, 62 (1994) 1079-1092.
29. Sharp, F.R., Jasper, P., Hall, J., Noble, L. and Sagar, S.M., MK-801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex, Ann. Neurol., 30 (1991) 801-809.
30. Wozniak, D.F., McEwen, M., Sesma, M.A., Olney, J.W. and Fix, A.S., MK-801 induces extensive neuronal necrosis in posterior cingulate/retrosplenial cortices, Soc. Neurosci. Abstr., 19 (1993) 1770.